Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
08 2019
Historique:
received: 18 03 2018
revised: 03 10 2018
accepted: 12 10 2018
pubmed: 23 10 2018
medline: 23 1 2020
entrez: 23 10 2018
Statut: ppublish

Résumé

The relationship between acute phase perioperative hyperglycemia and postoperative outcome is poorly understood. Retrospective cohort study of diabetic and non-diabetic adult patients undergoing non-cardiac surgery. Mean glucose and glycemic variability during the intraoperative and immediate postoperative periods were compared to length of stay, 30-day mortality, and postoperative complications. . DIABETIC PATIENTS (N = 1096): Higher glycemic variability was associated with longer hospital length of stay (0.32 day per 10 mg/dL) and greater 30-day mortality risk (OR = 1.42). Higher mean glucose (OR = 1.07) and glycemic variability (OR = 1.11) were associated with higher risk of complications. NON-DIABETIC PATIENTS (N = 1012): Both higher mean glucose (0.29 day per 10 mg/dL) and higher glycemic variability (0.68 day per 10 mg/dL) were associated with longer hospital length of stay. Both higher mean glucose (OR = 1.13) and higher glycemic variability (OR = 1.21) were associated with greater risks of complications. Poor acute phase perioperative glycemic control is associated with poor outcome, but differently in diabetic and non-diabetic patients suggesting different glycemic management strategies for the two patient groups.

Sections du résumé

BACKGROUND
The relationship between acute phase perioperative hyperglycemia and postoperative outcome is poorly understood.
METHODS
Retrospective cohort study of diabetic and non-diabetic adult patients undergoing non-cardiac surgery. Mean glucose and glycemic variability during the intraoperative and immediate postoperative periods were compared to length of stay, 30-day mortality, and postoperative complications.
RESULTS
. DIABETIC PATIENTS (N = 1096): Higher glycemic variability was associated with longer hospital length of stay (0.32 day per 10 mg/dL) and greater 30-day mortality risk (OR = 1.42). Higher mean glucose (OR = 1.07) and glycemic variability (OR = 1.11) were associated with higher risk of complications. NON-DIABETIC PATIENTS (N = 1012): Both higher mean glucose (0.29 day per 10 mg/dL) and higher glycemic variability (0.68 day per 10 mg/dL) were associated with longer hospital length of stay. Both higher mean glucose (OR = 1.13) and higher glycemic variability (OR = 1.21) were associated with greater risks of complications.
CONCLUSIONS
Poor acute phase perioperative glycemic control is associated with poor outcome, but differently in diabetic and non-diabetic patients suggesting different glycemic management strategies for the two patient groups.

Identifiants

pubmed: 30343876
pii: S0002-9610(18)30430-6
doi: 10.1016/j.amjsurg.2018.10.024
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

302-310

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Bala G Nair (BG)

Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA. Electronic address: nairbg@uw.edu.

Moni B Neradilek (MB)

The Mountain-Whisper-Light Statistics LLC, Seattle, WA, USA. Electronic address: moni@mwlight.com.

Shu-Fang Newman (SF)

Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA. Electronic address: sufu@uw.edu.

Mayumi Horibe (M)

Department of Anesthesiology, VA Puget Sound Health Care System, Seattle, WA, USA. Electronic address: Mayumi.Horibe@va.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH